Approaches to informed consent for hypothesis-testing and hypothesis-generating clinical genomics research

BMC Medical Genomics

Leslie G Biesecker²  Amy Linn¹  Julie C Sapp²  Flavia M Facio² 

[1] current affiliation: Kennedy Krieger Institute, Baltimore, MD, USA;National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA

关键词: Informed consent;    Whole exome sequencing;    Whole genome sequencing;   

Others  :  1134585
DOI  :  10.1186/1755-8794-5-45

 received in 2011-11-07, accepted in 2012-10-05,  发布年份 2012

【 摘 要 】

Background

Massively-parallel sequencing (MPS) technologies create challenges for informed consent of research participants given the enormous scale of the data and the wide range of potential results.

Discussion

We propose that the consent process in these studies be based on whether they use MPS to test a hypothesis or to generate hypotheses. To demonstrate the differences in these approaches to informed consent, we describe the consent processes for two MPS studies. The purpose of our hypothesis-testing study is to elucidate the etiology of rare phenotypes using MPS. The purpose of our hypothesis-generating study is to test the feasibility of using MPS to generate clinical hypotheses, and to approach the return of results as an experimental manipulation. Issues to consider in both designs include: volume and nature of the potential results, primary versus secondary results, return of individual results, duty to warn, length of interaction, target population, and privacy and confidentiality.

Summary

The categorization of MPS studies as hypothesis-testing versus hypothesis-generating can help to clarify the issue of so-called incidental or secondary results for the consent process, and aid the communication of the research goals to study participants.

【 授权许可】

   
2012 Facio et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Netzer C, Klein C, Kohlhase J, Kubisch C: New challenges for informed consent through whole genome array testing. J Med Genet 2009, 46:495-496.
• [2]McGuire AL, Beskow LM: Informed consent in genomics and genetic research. Annu Rev Genomics Hum Genet 2010, 11:361-381.
• [3]Bookman EB, Langehorne AA, Eckfeldt JH, Glass KC, Jarvik GP, Klag M, Koski G, Motulsky A, Wilfond B, Manolio TA, Fabsitz RR, Luepker RV, NHLBI Working Group: Reporting genetic results in research studies: Summary and recommendations of an NHLBI Working Group. Am J Med Genet A 2006, 140:1033-1040.
• [4]Ng PC, Kirkness EF: Whole genome sequencing. Methods Mol Biol 2010, 628:215-226.
• [5]Mascalzoni D, Hicks A, Pramstaller P, Wjst M: Informed consent in the genomics era. PLoS Med 2008, 5:e192.
• [6]Rotimi CN, Marshall PA: Tailoring the process of informed consent in genetic and genomic research. Genome Med 2010, 2:20. BioMed Central Full Text
• [7]Bredenoord AL, Kroes HY, Cuppen E, Parker M, van Delden JJ: Disclosure of individual genetic data to research participants: the debate reconsidered. Trends Genet 2011, 27:41-47.
• [8]Kronenthal C, Delaney SK, Christman MF: Broadening research consent in the era of genome-informed medicine. Genet Med 2012, 14:432-436.
• [9]Forsberg JS, Hansson MG, Eriksson S: Changing perspectives in biobank research: from individual rights to concerns about public health regarding the return of results. Eur J Hum Genet 2009, 17:1544-1549.
• [10]Shalowitz DI, Miller FG: Disclosing individual results of clinical research: implications of respect for participants. JAMA 2005, 294:737-740.
• [11]Fernandez CV, Kodish E, Weijer C: Informing study participants of research results: an ethical imperative. IRB 2003, 25:12-19.
• [12]McGuire AL, Lupski JR: Personal genome research: what should the participant be told? Trends Genet 2010, 26:199-201.
• [13]Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, Fletcher JG, Georgieff MK, Hammerschmidt D, Hudson K, Illes J, Kapur V, Keane MA, Koenig BA, Leroy BS, McFarland EG, Paradise J, Parker LS, Terry SF, Van Ness B, Wilfond BS: Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics 2008, 36:219-248.
• [14]Kohane IS, Taylor PL: Multidimensional results reporting to participants in genomic studies: Getting it right. Sci Transl Med 2010, 2:37cm19.
• [15]Fabsitz RR, McGuire A, Sharp RR, Puggal M, Beskow LM, Biesecker LG, Bookman E, Burke W, Burchard EG, Church G, Clayton EW, Eckfeldt JH, Fernandez CV, Fisher R, Fullerton SM, Gabriel S, Gachupin F, James C, Jarvik GP, Kittles R, Leib JR, O'Donnell C, O'Rourke PP, Rodriguez LL, Schully SD, Shuldiner AR, Sze RK, Thakuria JV, Wolf SM, Burke GL, National Heart, Lung, and Blood Institute working group: Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a national heart, lung, and blood institute working group. Circ Cardiovasc Genet 2010, 3:574-580.
• [16]Facio FM, Fisher T, Eidem H, Brooks S, Linn A, Biesecker LG, Biesecker BB: Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeqTM study. Eu J Hum Genetin press
• [17]Morton NE: The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type. Am J Hum Genet 1956, 8:80-96.
• [18]Morton NE: The mutational load due to detrimental genes in man. Am J Hum Genet 1960, 12:348-364.
• [19]Biesecker LG, Mullikin JC, Facio FM, Turner C, Cherukuri PF, Blakesley RW, Bouffard GG, Chines PS, Cruz P, Hansen NF, Teer JK, Maskeri B, Young AC, Manolio TA, Wilson AF, Finkel T, Hwang P, Arai A, Remaley AT, Sachdev V, Shamburek R, Cannon RO, Green ED, NISC Comparative Sequencing Program: The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res 2009, 19:1665-1674.
• [20]Kohane IS, Mandl KD, Taylor PL, Holm IA, Nigrin DJ, Kunkel LM: Medicine. Reestablishing the researcher-patient compact. Science 2007, 316:836-837.
• [21]Lin Z, Owen AB, Altman RB: Genomic Research and Human Subject Privacy. Science 2004, 305:183.
• [22]Homer N, Szelinger S, Redman M, Duggan D, Tembe W, Muehling J, Pearson JV, Stephan DA, Nelson SF, Craig DW: Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet 2008, 29:e1000167.
• [23]Facio FM, Brooks S, Loewenstein J, Green S, Biesecker LG, Biesecker BB: Motivators for participation in a whole-genome sequencing study: implications for translational genomics research. Eur J Hum Genet 2011, 19:1213-1217.